Simultaneous in vitro exposure to STI-571, APO2L/TRAIL and interferon-alpha, with or without prior Ara-C treatment, APO2L/TRAIL-induced cytotoxicity and apoptosis in BCR/ABL plus leukemic blasts

被引：0
|
作者：
Martinelli, G
Ottaviani, E
Rosti, G
Grafone, T
Amabile, M
Giannini, B
Terragna, C
Zardini, C
Buonamici, S
Soverini, S
Trabacchi, E
Bassi, S
De Vivo, A
Bonifazi, F
Alberti, D
Tura, S
Baccarani, M
机构：
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O241
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 24 条
  • [1] Simultaneous in vitro exposure to Glivec® (formerly STI571), Apo2L/TRAIL and interferon-alpha, with or without prior Ara-C treatment, Apo2L/TRAIL-induced cytotoxicity and apoptosis in BCR/ABL plus leukemic blasts.
    Ottaviani, E
    Martinelli, G
    Rosti, G
    Grafone, T
    Amabile, M
    Giannini, B
    Terragna, C
    Zardini, C
    Buonamici, S
    Soverini, S
    Trabacchi, E
    Bassi, S
    De Vivo, A
    Bonifazi, F
    Alberti, D
    Tura, S
    Baccarani, N
    BLOOD, 2001, 98 (11) : 265B - 266B
  • [2] Cellular pathways mediating APO2L/TRAIL-induced apoptosis in glioma cells
    Rieger, J
    Weller, M
    Frank, B
    Wick, W
    NEURO-ONCOLOGY, 2005, 7 (03) : 317 - 317
  • [3] Defining the mechanisms of APO2L/trail-induced apoptosis in authentic multiple myeloma cells
    Koutrouvelis, KC
    Yeh, SL
    Baulch-Brown, C
    Spencer, A
    EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) : 64 - 64
  • [4] Curcurain enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells
    Wahl, Heather
    Tan, Lijun
    Griffith, Kent
    Choi, Miheon
    Liu, J. Rebecca
    GYNECOLOGIC ONCOLOGY, 2007, 105 (01) : 104 - 112
  • [5] Apo2L/TRAIL is an indirect mediator of apoptosis induced by interferon-α in human myeloma cells
    Gómez-Benito, M
    Balsas, P
    Bosque, A
    Anel, A
    Marzo, I
    Naval, J
    FEBS LETTERS, 2005, 579 (27): : 6217 - 6222
  • [6] Monocyte-Macrophage Differentiation Suppresses the Expression of Proapoptotic Receptors to Apo2L/TRAIL and Increases Resistance to TRAIL-Induced Apoptosis
    Evstratova Y.V.
    Kobyakova M.I.
    Novikova V.V.
    Senotov A.S.
    Akatov V.S.
    Fadeev R.S.
    Biophysics, 2019, 64 (5) : 729 - 731
  • [7] Osteoprotegerin (OPG) is a soluble decoy receptor for TRAIL/Apo2L and can inhibit TRAIL/Apo2L-induced apoptosis of human myeloma cells in vitro.
    Shipman, CM
    Croucher, PI
    BLOOD, 2002, 100 (11) : 208A - 208A
  • [8] Insulin-like growth factor (IGF) sensitises Ewing tumour cells to Apo2L/TRAIL-induced apoptosis
    Hotfilder, M.
    Juergens, H.
    van Valen, F.
    KLINISCHE PADIATRIE, 2008, 220 (03): : 210 - 210
  • [9] Wnt-expressing rat embryonic fibroblasts suppress Apo2L/TRAIL-induced apoptosis of human leukemia cells
    Doubravska, Lenka
    Simova, Sarka
    Cermak, Lukas
    Valenta, Tomas
    Korinek, Vladimir
    Andera, Ladislav
    APOPTOSIS, 2008, 13 (04) : 573 - 587
  • [10] BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosis
    Mott, Justin L.
    Bronk, Steve F.
    Mesa, Ruben A.
    Kaufmann, Scott H.
    Gores, Gregory J.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (08) : 2339 - 2347
123